Simultaneous administration of control-released basic fibroblast growth factor enhances the efficacy of skeletal myoblast transplantation by increasing vascular density and graft volume
- Publication date
- 1 January 2003
- Publisher
- 'Ovid Technologies (Wolters Kluwer Health)'
